BL
PFE icon

BCWM LLC’s Pfizer PFE Stock Holding History

BCWM LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.17M Buy
219,730
+20,052
+10% +$534K 1.75% 29
2025
Q4 		$4.97M Buy
199,678
+49
+0% +$1.24K 1.49% 29
2025
Q3 		$5.09M Buy
199,629
+3,046
+2% +$75.2K 1.52% 28
2025
Q2 		$4.77M Buy
196,583
+17,775
+10% +$415K 1.51% 33
2025
Q1 		$4.53M Buy
178,808
+18,083
+11% +$473K 1.57% 29
2024
Q4 		$4.26M Buy
+160,725
New +$4.36M 1.52% 28
2024
Q2 		$4.78M Buy
+170,885
New +$4.7M 1.72% 25

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BCWM LLC's PFE Position: Q1 2026 in Review

BCWM LLC increased its Pfizer (PFE) stake by 10% in Q1 2026, buying an estimated $534K and bringing the position to 219,730 shares worth $6.17M. The position accounts for 1.75% of the portfolio, ranked #29.

BCWM LLC first reported a position in PFE in Q2 2024 and has held it in 7 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • BCWM LLC held 219,730 shares of Pfizer worth $6.17M as of Q1 2026.
  • BCWM LLC bought 20,052 Pfizer shares in Q1 2026, an estimated $534K.
  • Pfizer made up 1.75% of BCWM LLC's portfolio in Q1 2026, its #29 holding.
  • BCWM LLC first reported a position in Pfizer in Q2 2024 and has held it in 7 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BCWM LLC's 13F filing for Q1 2026, filed 14 May 2026.